Trial Profile
Dobutamine-induced increase in heart rate is blunted by ivabradine treatment in patients with acutely decompensated heart failure
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Sep 2012
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary)
- Indications Decompensated heart failure
- Focus Pharmacodynamics
- 07 Sep 2012 New trial record
- 29 Aug 2012 Results presented at the ESC Congress 2012: Annual Congress of the European Society of Cardiology.